BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17275413)

  • 1. Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis.
    Sfikakis PP; Souliotis VL; Fragiadaki KG; Moutsopoulos HM; Boletis JN; Theofilopoulos AN
    Clin Immunol; 2007 Apr; 123(1):66-73. PubMed ID: 17275413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial.
    Sfikakis PP; Boletis JN; Lionaki S; Vigklis V; Fragiadaki KG; Iniotaki A; Moutsopoulos HM
    Arthritis Rheum; 2005 Feb; 52(2):501-13. PubMed ID: 15693003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.
    Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL
    Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
    Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXP3 expression in blood, synovial fluid and synovial tissue during inflammatory arthritis and intra-articular corticosteroid treatment.
    Raghavan S; Cao D; Widhe M; Roth K; Herrath J; Engström M; Roncador G; Banham AH; Trollmo C; Catrina AI; Malmström V
    Ann Rheum Dis; 2009 Dec; 68(12):1908-15. PubMed ID: 19066178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How and when to pick up the best signals from markers associated with T-regulatory cells?
    Kivling A; Nilsson L; Faresjö M
    J Immunol Methods; 2009 Jun; 345(1-2):29-39. PubMed ID: 19341742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
    Biagi E; Di Biaso I; Leoni V; Gaipa G; Rossi V; Bugarin C; Renoldi G; Parma M; Balduzzi A; Perseghin P; Biondi A
    Transplantation; 2007 Jul; 84(1):31-9. PubMed ID: 17627234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary FOXP3 mRNA in patients with lupus nephritis--relation with disease activity and treatment response.
    Wang G; Lai FM; Tam LS; Li EK; Kwan BC; Chow KM; Li PK; Szeto CC
    Rheumatology (Oxford); 2009 Jul; 48(7):755-60. PubMed ID: 19458162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and functional activity of Th17, Tc17 and other T-cell subsets in Systemic Lupus Erythematosus.
    Henriques A; Inês L; Couto M; Pedreiro S; Santos C; Magalhães M; Santos P; Velada I; Almeida A; Carvalheiro T; Laranjeira P; Morgado JM; Pais ML; da Silva JA; Paiva A
    Cell Immunol; 2010; 264(1):97-103. PubMed ID: 20553755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis.
    Bonelli M; von Dalwigk K; Savitskaya A; Smolen JS; Scheinecker C
    Ann Rheum Dis; 2008 May; 67(5):664-71. PubMed ID: 17728327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of T-regulatory cells in cord blood of atopic mothers.
    Schaub B; Liu J; Höppler S; Haug S; Sattler C; Lluis A; Illi S; von Mutius E
    J Allergy Clin Immunol; 2008 Jun; 121(6):1491-9, 1499.e1-13. PubMed ID: 18539197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barré syndrome.
    Chi LJ; Wang HB; Zhang Y; Wang WZ
    J Neuroimmunol; 2007 Dec; 192(1-2):206-14. PubMed ID: 17997492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma.
    Lee JH; Yu HH; Wang LC; Yang YH; Lin YT; Chiang BL
    Clin Exp Immunol; 2007 Apr; 148(1):53-63. PubMed ID: 17349011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-beta.
    Satoguina JS; Adjobimey T; Arndts K; Hoch J; Oldenburg J; Layland LE; Hoerauf A
    Eur J Immunol; 2008 Nov; 38(11):3101-13. PubMed ID: 18924213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD3 mAb treatment ameliorated the severity of the cGVHD-induced lupus nephritis in mice by up-regulation of Foxp3+ regulatory T cells in the target tissue: kidney.
    Zhang JL; Sun DJ; Hou CM; Wei YL; Li XY; Yu ZY; Feng JN; Shen BF; Li Y; Xiao H
    Transpl Immunol; 2010 Oct; 24(1):17-25. PubMed ID: 20850528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forkhead box P3 (FOXP3) mRNA expression immediately after living-donor liver transplant.
    Sakamoto R; Asonuma K; Zeledon Ramirez ME; Yoshimoto K; Nishimori A; Inomata Y
    Exp Clin Transplant; 2009 Mar; 7(1):8-12. PubMed ID: 19364305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.